AEterna Zentaris to Present at Upcoming UBS Global Life Sciences Conference in New York

QUEBEC CITY, Sept. 20 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (TSX:AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrinetherapy and oncology, today announced that its President and CEO, David J.Mazzo, Ph.D., will present a Company overview at the UBS Global Life SciencesConference on Thursday, September 27, 2007 at 10:00 a.m. Eastern, in theBallroom E of the Grand Hyatt Hotel in New York City.

A live webcast of this presentation will be available on AEterna Zentaris'website at www.aeternazentaris.com in the Investors section. A replay willalso be available for a period of 30 days on the Company's website.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is global biopharmaceutical company focused onendocrine therapy and oncology with proven expertise in drug discovery,development and commercialization.

News releases and additional information are available atwww.aeternazentaris.com.

SOURCE AETERNA ZENTARIS INC.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...